Evaluating Sclerostin as a Biomarker for Bone Health in Hyperthyroidism: A Clinical and Hormonal Correlation Study
Serum sclerostin levels are significantly associated with thyroid hormone status in hyperthyroid individuals. These findings suggest that sclerostin may serve as a potential biomarker for monitoring bone health in thyroid dysfunction. Further large-scale, longitudinal studies are warranted to confirm its diagnostic and prognostic utility.
Authors
- Hemkant Patil
- Panneerselvam Periasamy
- Shilpa Nagar
- S. Lakshmi Prabha
- S. Ayyappan
- Ilanchezhian Thambidurai
Institutions
- Government Medical College (IN)
- Tamil Nadu Government Dental College and Hospital (IN)
- ACPM Dental College and Hospital (IN)
- Vinayaka Missions Medical College and Hospitals (IN)
Publication Details
- Journal
- Journal of Pharmacy And Bioallied Sciences
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4103/jpbs.jpbs_1023_25
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00